Betaxolol hydrochloride
Code | Size | Price |
---|
TAR-T0226-1mL | 1 mL * 10 mM (in DMSO) | £101.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0226-10mg | 10mg | £105.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0226-25mg | 25mg | £114.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0226-50mg | 50mg | £132.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0226-100mg | 100mg | £174.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T0226-200mg | 200mg | £201.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Betaxolol is a cardioselective beta-blocker used in the treatment of hypertension. Betaxolol has not been linked to instances of clinically apparent drug induced liver injury.
CAS:
63659-19-8
Formula:
C18H30ClNO3
Molecular Weight:
343.89
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.9956
SMILES:
Cl.CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1
Target:
Adrenergic Receptor
References
1. Tang LQ, et al. Curr Eye Res, 1998, 17(1), 24-30.
2. Wood JP, et al. Exp Eye Res, 2003, 76(4), 505-516.
3. Osborne NN,et al. Exp Eye Res, 1999, 69(3), 331-342.